These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20854782)

  • 1. Pharmacogenomics of methylphenidate response: making progress.
    Mrazek DA
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1140-2. PubMed ID: 20854782
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine and pharmacogenomics in child psychiatry.
    Rockhill C; Althoff RR
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1136. PubMed ID: 20854780
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder.
    Masellis M; Basile VS; Muglia P; Ozdemir V; Macciardi FM; Kennedy JL
    Behav Brain Res; 2002 Mar; 130(1-2):85-90. PubMed ID: 11864722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
    Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
    J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD.
    Contini V; Victor MM; Bertuzzi GP; Salgado CA; Picon FA; Grevet EH; Rohde LA; Belmonte-de-Abreu P; Bau CH
    J Clin Psychopharmacol; 2012 Dec; 32(6):820-3. PubMed ID: 23131881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.
    Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V
    Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).
    Purper-Ouakil D; Wohl M; Orejarena S; Cortese S; Boni C; Asch M; Mouren MC; Gorwood P
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1425-30. PubMed ID: 18563707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
    J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?
    Mulder R; Hazell P; Rucklidge JJ; Malhi GS
    Aust N Z J Psychiatry; 2016 Feb; 50(2):113-4. PubMed ID: 26823533
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.
    Shaw P
    JAMA; 2016 May; 315(18):1953-5. PubMed ID: 27163984
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief report: response to methylphenidate in two children with Williams syndrome.
    Power TJ; Blum NJ; Jones SM; Kaplan PE
    J Autism Dev Disord; 1997 Feb; 27(1):79-87. PubMed ID: 9018583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 15. Scientists examine benefits, risks of treating preschoolers with ADHD drugs.
    Kuehn BM
    JAMA; 2007 Oct; 298(15):1747-9. PubMed ID: 17940222
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response.
    da Silva BS; Leffa DT; Beys-da-Silva WO; Torres ILS; Rovaris DL; Victor MM; Rohde LA; Mota NR; Oliveira C; Berger M; Yates JR; Sabnis R; Peña RD; Campos AR; Grevet EH; Santi L; Bau CHD; Contini V
    Transl Psychiatry; 2019 Nov; 9(1):308. PubMed ID: 31740662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S; Tanidir C
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract]   [Full Text] [Related]  

  • 20. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.